Citation Tools

Download PDFPDF

Original article
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation

Download to a citation manager

Cite this article as:
Clancy JP, Rowe SM, Accurso FJ, et al
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation